论文部分内容阅读
目的:观察老年中晚期前列腺癌患者内分泌综合治疗临床效果。方法:选择2009年8月-2016年4月期间在我院接受治疗的老年中晚期前列腺癌患者89例作为研究对象,随机划入观察组和对照组,其中观察组44例,对照组45例,分别接受内分泌综合治疗和手术治疗,比较两组患者的3年存活率。结果:观察组患者1年存活44例,2年存活40例,3年存活33例,3年存活率75.0%,对照组患者1年存活45例,2年存活40例,3年存活24例,3年存活率53.3%,观察组患者3年存活率高于对照组,组间差异有统计学意义,P<0.05。结论:老年中晚期前列腺癌患者内分泌综合治疗临床效果显著,3年存活率高于放射治疗,值得临床应用和推广。
Objective: To observe the clinical effect of endocrine comprehensive treatment in elderly patients with advanced prostate cancer. Methods: 89 elderly patients with advanced prostate cancer who were treated in our hospital from August 2009 to April 2016 were selected as study subjects and randomly divided into observation group and control group, 44 cases in observation group and 45 cases in control group , Respectively, to accept endocrine comprehensive treatment and surgical treatment, comparing the two groups of patients 3-year survival rate. Results: In the observation group, there were 44 cases in one year, 40 cases in 2 years, 33 cases in 3 years and 75.0% in 3 years, 45 cases in control group in 1 year, 40 cases in 2 years and 24 cases in 3 years. , The 3-year survival rate was 53.3%. The 3-year survival rate in the observation group was higher than that in the control group. There was significant difference between the two groups (P <0.05). Conclusion: The clinical effect of endocrine comprehensive treatment for advanced prostate cancer patients is remarkable. The 3-year survival rate is higher than radiotherapy, which is worthy of clinical application and promotion.